{"id":5143,"date":"2022-05-16T01:50:51","date_gmt":"2022-05-16T01:50:51","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=5143"},"modified":"2023-08-29T18:01:34","modified_gmt":"2023-08-29T18:01:34","slug":"pharmaust-receives-tablets-motor-neurone-disease-clinical-trial","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=5143","title":{"rendered":"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242"},"content":{"rendered":"<p style=\"font-weight: 400;\">PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p style=\"font-weight: 400;\">\u8fd9\u5bb6\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u6280\u672f\u516c\u53f8\u4eca\u5929\u62a5\u544a\u4e86\u5f53\u524d\u826f\u597d\u751f\u4ea7\u89c4\u8303 (cGMP) \u7ea7\u7247\u5242\u7684\u95ee\u4e16\uff0c\u8be5\u7247\u5242\u7ecf\u8fc7\u4e13\u95e8\u8bbe\u8ba1\uff0c\u5177\u6709\u4e0d\u540c\u7684\u5f62\u72b6\u548c\u5927\u5c0f\uff0c\u4ee5\u5e2e\u52a9 MND \u60a3\u8005\u541e\u54bd\u5e76\u8fbe\u5230\u9488\u5bf9\u8be5\u75be\u75c5\u7684\u7279\u5b9a\u8840\u6db2\u836f\u7269\u6c34\u5e73\u3002<\/p>\n<p style=\"font-weight: 400;\">\u7247\u5242\u7684\u9884\u53d1\u5e03\u6280\u672f\u89c4\u683c\u8868\u660e\u5df2\u8fbe\u5230\u8bd5\u9a8c\u6240\u9700\u7684\u7a33\u5b9a\u6027\u89c4\u683c\u3002 PharmAust \u73b0\u5728\u6b63\u5728\u7b49\u5f85\u5236\u9020\u5546\u7b7e\u7f72\u7684\u6280\u672f\u6587\u4ef6\u3002<\/p>\n<p style=\"font-weight: 400;\">PharmAust \u8868\u793a\uff0c\u7b2c\u4e8c\u6279\u5907\u7528\u8d27\u7269\u7684\u8fd0\u8f93\u6587\u4e66\u5de5\u4f5c\u5df2\u7ecf\u5b8c\u6210\uff0c\u8fd9\u4e9b\u5e73\u677f\u7535\u8111\u6b63\u5728\u8fd0\u5f80\u58a8\u5c14\u672c\u7684\u9014\u4e2d\uff0c\u9884\u8ba1\u5c06\u4e8e\u672c\u5468\u665a\u4e9b\u65f6\u5019\u62b5\u8fbe\u3002<\/p>\n<h2 style=\"font-weight: 400;\">\u8fd0\u52a8\u795e\u7ecf\u5143\u75c5\u4e34\u5e8a\u8bd5\u9a8c<\/h2>\n<p style=\"font-weight: 400;\">\u8be5\u4e34\u5e8a\u8bd5\u9a8c\u5f97\u5230\u4e86\u6fb3\u5927\u5229\u4e9a\u6700\u5927\u7684 MND \u7814\u7a76\u72ec\u7acb\u8d44\u52a9\u8005 FightMND \u7684\u652f\u6301\u3002\u81ea 2014 \u5e74\u4ee5\u6765\uff0c\u8be5\u7ec4\u7ec7\u5df2\u5411MND \u7814\u7a76\u548c\u62a4\u7406\u8bbe\u5907\u6295\u8d44\u8d85\u8fc7 6300 \u4e07\u6fb3\u5143\u3002<\/p>\n<p style=\"font-weight: 400;\">2020 \u5e74\uff0c<a href=\"http:\/\/smallcaps-production.test\/pharmaust-moves-closer-clinical-trial-mpl-motor-neuron-disease\/?lang=cn\">FightMND \u627f\u8bfa\u4e3a\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u7814\u7a76\u63d0\u4f9b\u8d85\u8fc7 880,000 \u6fb3\u5143<\/a>\u7684\u8d44\u91d1\uff0c\u5c06\u5728 PharmAust \u5b8c\u6210\u91cc\u7a0b\u7891\u540e\u5206\u671f\u652f\u4ed8\u3002\u5ba1\u5224\u5f00\u59cb\u540e\uff0c\u6700\u540e\u4e00\u671f\u5c31\u5230\u671f\u4e86\u3002<\/p>\n<p style=\"font-weight: 400;\">\u5728\u4eca\u5929\u7684\u66f4\u65b0\u4e2d\uff0cPharmAust \u8868\u793a\uff0c\u5f00\u59cb MND \u8bd5\u9a8c\u7684\u8f85\u52a9\u51c6\u5907\u5de5\u4f5c\u201c\u5927\u90e8\u5206\u5b8c\u6210\u201d\uff0c\u9664\u4e86\u4e00\u4e9b\u6280\u672f\u548c\u76d1\u7ba1\u6279\u51c6\u4ee5\u53ca\u7247\u5242\u4e2d\u5c11\u91cf\u6742\u8d28\u7684\u8868\u5f81\u3002\u6240\u6709\u5269\u4f59\u7684\u5de5\u4f5c\u9884\u8ba1\u5c06\u5728 5 \u6708\u5e95\u4e4b\u524d\u5b8c\u6210\u3002<\/p>\n<p style=\"font-weight: 400;\">\u8be5\u516c\u53f8\u6307\u51fa\uff0c\u5728\u6700\u7ec8\u6cbb\u7406\u7b7e\u7f72\u4e4b\u524d\uff0c\u65e0\u6cd5\u5f00\u59cb\u62db\u8058\uff0c\u56e0\u4e3a\u8fd9\u662f\u6fc0\u6d3b\u6cbb\u7597\u7528\u54c1\u7ba1\u7406\u5c40 (TGA) \u7684\u4e34\u5e8a\u8bd5\u9a8c\u901a\u77e5\u8bb8\u53ef\u8bc1\u7684\u65f6\u95f4\u3002<\/p>\n<p style=\"font-weight: 400;\">PharmAust \u9996\u5e2d\u79d1\u5b66\u5b98 Richard Mollard \u535a\u58eb\u8bf4\uff1a\u201c\u968f\u7740\u5269\u4f59\u51c6\u5907\u5de5\u4f5c\u63a5\u8fd1\u5b8c\u6210\uff0c\u4e00\u65e6\u7b7e\u7f72\u533b\u9662\u6cbb\u7406\u534f\u8bae\uff0c\u5c06\u6b63\u5f0f\u5f00\u59cb\u4e0e\u6f5c\u5728\u5e94\u8ba1\u9879\u76ee\u7684\u8ba8\u8bba\u3002\u201d<\/p>\n<p style=\"font-weight: 400;\">PharmAust \u7684\u4e3b\u8981\u5019\u9009\u836f\u7269 MPL \u6b64\u524d\u5df2\u5728\u7b2c\u4e00\u9636\u6bb5\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8fdb\u884c\u4e86\u8bc4\u4f30\uff0c\u53d1\u73b0\u8be5\u6cbb\u7597\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\u5e76\u663e\u793a\u51fa\u6297\u764c\u6d3b\u6027\u7684\u521d\u6b65\u8bc1\u636e\u3002<\/p>\n<p style=\"font-weight: 400;\">\u8be5\u836f\u7269\u8fd8\u5728\u72d7\u8eab\u4e0a\u8fdb\u884c\u4e86\u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u8fd9\u5bb6\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u6280\u672f\u516c\u53f8\u4eca\u5929\u62a5\u544a\u4e86\u5f53\u524d\u826f\u597d\u751f\u4ea7\u89c4\u8303 (cGMP) \u7ea7\u7247\u5242\u7684\u95ee\u4e16\uff0c\u8be5\u7247\u5242\u7ecf\u8fc7\u4e13\u95e8\u8bbe\u8ba1\uff0c\u5177\u6709\u4e0d\u540c\u7684\u5f62\u72b6\u548c\u5927\u5c0f\uff0c\u4ee5\u5e2e\u52a9 MND \u60a3\u8005\u541e\u54bd\u5e76\u8fbe\u5230\u9488\u5bf9\u8be5\u75be\u75c5\u7684\u7279\u5b9a\u8840\u6db2\u836f\u7269\u6c34\u5e73\u3002 \u7247\u5242\u7684\u9884\u53d1\u5e03\u6280\u672f\u89c4\u683c\u8868\u660e\u5df2\u8fbe\u5230\u8bd5\u9a8c\u6240\u9700\u7684\u7a33\u5b9a\u6027\u89c4\u683c\u3002 PharmAust \u73b0\u5728\u6b63\u5728\u7b49\u5f85\u5236\u9020\u5546\u7b7e\u7f72\u7684\u6280\u672f\u6587\u4ef6\u3002 PharmAust \u8868\u793a\uff0c\u7b2c\u4e8c\u6279\u5907\u7528\u8d27\u7269\u7684\u8fd0\u8f93\u6587\u4e66\u5de5\u4f5c\u5df2\u7ecf\u5b8c\u6210\uff0c\u8fd9\u4e9b\u5e73\u677f\u7535\u8111\u6b63\u5728\u8fd0\u5f80\u58a8\u5c14\u672c\u7684\u9014\u4e2d\uff0c\u9884\u8ba1\u5c06\u4e8e\u672c\u5468\u665a\u4e9b\u65f6\u5019\u62b5\u8fbe\u3002 \u8fd0\u52a8\u795e\u7ecf\u5143\u75c5\u4e34\u5e8a\u8bd5\u9a8c \u8be5\u4e34\u5e8a\u8bd5\u9a8c\u5f97\u5230\u4e86\u6fb3\u5927\u5229\u4e9a\u6700\u5927\u7684 MND \u7814\u7a76\u72ec\u7acb\u8d44\u52a9\u8005 FightMND \u7684\u652f\u6301\u3002\u81ea 2014 \u5e74\u4ee5\u6765\uff0c\u8be5\u7ec4\u7ec7\u5df2\u5411MND \u7814\u7a76\u548c\u62a4\u7406\u8bbe\u5907\u6295\u8d44\u8d85\u8fc7 6300 \u4e07\u6fb3\u5143\u3002 2020 \u5e74\uff0cFightMND \u627f\u8bfa\u4e3a\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u7814\u7a76\u63d0\u4f9b\u8d85\u8fc7 880,000 \u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u5c06\u5728 PharmAust \u5b8c\u6210\u91cc\u7a0b\u7891\u540e\u5206\u671f\u652f\u4ed8\u3002\u5ba1\u5224\u5f00\u59cb\u540e\uff0c\u6700\u540e\u4e00\u671f\u5c31\u5230\u671f\u4e86\u3002 \u5728\u4eca\u5929\u7684\u66f4\u65b0\u4e2d\uff0cPharmAust \u8868\u793a\uff0c\u5f00\u59cb MND \u8bd5\u9a8c\u7684\u8f85\u52a9\u51c6\u5907\u5de5\u4f5c\u201c\u5927\u90e8\u5206\u5b8c\u6210\u201d\uff0c\u9664\u4e86\u4e00\u4e9b\u6280\u672f\u548c\u76d1\u7ba1\u6279\u51c6\u4ee5\u53ca\u7247\u5242\u4e2d\u5c11\u91cf\u6742\u8d28\u7684\u8868\u5f81\u3002\u6240\u6709\u5269\u4f59\u7684\u5de5\u4f5c\u9884\u8ba1\u5c06\u5728 5 \u6708\u5e95\u4e4b\u524d\u5b8c\u6210\u3002 \u8be5\u516c\u53f8\u6307\u51fa\uff0c\u5728\u6700\u7ec8\u6cbb\u7406\u7b7e\u7f72\u4e4b\u524d\uff0c\u65e0\u6cd5\u5f00\u59cb\u62db\u8058\uff0c\u56e0\u4e3a\u8fd9\u662f\u6fc0\u6d3b\u6cbb\u7597\u7528\u54c1\u7ba1\u7406\u5c40 (TGA) \u7684\u4e34\u5e8a\u8bd5\u9a8c\u901a\u77e5\u8bb8\u53ef\u8bc1\u7684\u65f6\u95f4\u3002 PharmAust \u9996\u5e2d\u79d1\u5b66\u5b98 Richard Mollard \u535a\u58eb\u8bf4\uff1a\u201c\u968f\u7740\u5269\u4f59\u51c6\u5907\u5de5\u4f5c\u63a5\u8fd1\u5b8c\u6210\uff0c\u4e00\u65e6\u7b7e\u7f72\u533b\u9662\u6cbb\u7406\u534f\u8bae\uff0c\u5c06\u6b63\u5f0f\u5f00\u59cb\u4e0e\u6f5c\u5728\u5e94\u8ba1\u9879\u76ee\u7684\u8ba8\u8bba\u3002\u201d PharmAust \u7684\u4e3b\u8981\u5019\u9009\u836f\u7269 MPL \u6b64\u524d\u5df2\u5728\u7b2c\u4e00\u9636\u6bb5\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8fdb\u884c\u4e86\u8bc4\u4f30\uff0c\u53d1\u73b0\u8be5\u6cbb\u7597\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\u5e76\u663e\u793a\u51fa\u6297\u764c\u6d3b\u6027\u7684\u521d\u6b65\u8bc1\u636e\u3002 \u8be5\u836f\u7269\u8fd8\u5728\u72d7\u8eab\u4e0a\u8fdb\u884c\u4e86\u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n","protected":false},"author":5,"featured_media":17928,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[241],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242<\/title>\n<meta name=\"description\" content=\"PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242\" \/>\n<meta property=\"og:description\" content=\"PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-16T01:50:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/PharmAust-ASX-PAA-Monepantel-MPL-tablets-Motor-Neuron-Disease-Clinical-Trial-Melbourne.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/\",\"name\":\"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-05-16T01:50:51+00:00\",\"dateModified\":\"2023-08-29T18:01:34+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242","description":"PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242","og_description":"PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/","og_site_name":"smallcapsCN","article_published_time":"2022-05-16T01:50:51+00:00","article_modified_time":"2023-08-29T18:01:34+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/PharmAust-ASX-PAA-Monepantel-MPL-tablets-Motor-Neuron-Disease-Clinical-Trial-Melbourne.jpg","type":"image\/jpeg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/","url":"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/","name":"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-05-16T01:50:51+00:00","dateModified":"2023-08-29T18:01:34+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"PharmAust (ASX: PAA) \u5728\u5c06\u7247\u5242\u8fd0\u9001\u5230\u58a8\u5c14\u672c\u7684\u8bd5\u9a8c\u5730\u70b9\u540e\uff0c\u6709\u671b\u5728\u672c\u6708\u5f00\u59cb\u5bf9\u5176\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u7684monepantel (MPL) \u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-receives-tablets-motor-neurone-disease-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"PharmAust \u6536\u5230\u7528\u4e8e\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7247\u5242"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5143"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5143"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5143\/revisions"}],"predecessor-version":[{"id":15022,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5143\/revisions\/15022"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/17928"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}